Literature DB >> 6401589

The effect of surgery and chemotherapy on blood NK cell activity in patients with ovarian cancer.

B Lukomska, W L Olszewski, A Engeset, P Kolstad.   

Abstract

The cytotoxic activity of NK cells in peripheral blood was studied in 15 patients with ovarian cancer Stage III and IV before and after surgery and ten-week intramuscular therapy with thiotepa. An evident decrease in NK activity was found 24 hours after surgery, with a slow return toward normal values within 7-9 days. No differences between patients with explorative laparotomy and with extirpation of the tumor were observed. The mechanism of the decreased NK cytotoxicity remains unknown but there was a concomitant reduction in the number of blood mononuclears. A second drop in NK activity occurred after chemotherapy. It was most likely due to the drug bone marrow depression. No evident correlation between the reduced NK activity and advancement of the disease could be found.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401589     DOI: 10.1002/1097-0142(19830201)51:3<465::aid-cncr2820510318>3.0.co;2-9

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  9 in total

Review 1.  Need for immunologic stimulators during immunosuppression produced by major cancer surgery.

Authors:  W H Cole; L Humphrey
Journal:  Ann Surg       Date:  1985-07       Impact factor: 12.969

2.  In vitro inhibition of natural-killer-mediated lysis by chromatin fragments.

Authors:  A D Le Lann; G J Fournié; L Boissier; P L Toutain; H Benoist
Journal:  Cancer Immunol Immunother       Date:  1994-09       Impact factor: 6.968

3.  Natural killer activity and serum immunosuppressive acidic protein levels in esophageal and gastric cancers.

Authors:  M Oka; H Mitsunaga; S Hazama; S Yoshino; T Suzuki
Journal:  Surg Today       Date:  1993       Impact factor: 2.549

4.  Effect of surgery on pancreatic tumor-dependent lymphocyte asset: modulation of natural killer cell frequency and cytotoxic function.

Authors:  Francesco Iannone; Alessandra Porzia; Giovanna Peruzzi; Patrizia Birarelli; Bernardina Milana; Luca Sacco; Giuseppe Dinatale; Nadia Peparini; Giampaolo Prezioso; Simone Battella; Roberto Caronna; Stefania Morrone; Gabriella Palmieri; Fabrizio Mainiero; Piero Chirletti
Journal:  Pancreas       Date:  2015-04       Impact factor: 3.327

Review 5.  Prospects for NK Cell Therapy of Sarcoma.

Authors:  Mieszko Lachota; Marianna Vincenti; Magdalena Winiarska; Kjetil Boye; Radosław Zagożdżon; Karl-Johan Malmberg
Journal:  Cancers (Basel)       Date:  2020-12-11       Impact factor: 6.639

6.  Application of a novel microscopic technique for quantifying CA125 binding to circulating mononuclear cells in longitudinal specimens during treatment for ovarian cancer.

Authors:  Kornél Lakatos; Germán González; Jawad Hoballah; Jeff Brooker; Sinyoung Jeong; Conor Evans; Petra Krauledat; W Peter Hansen; Kevin M Elias; Manish Patankar; Vilmos Fülöp; Panagiotis A Konstantinopoulos; Daniel W Cramer
Journal:  J Ovarian Res       Date:  2022-02-26       Impact factor: 4.234

7.  Accumulation of natural killer cells after hepatic artery embolisation in the midgut carcinoid syndrome.

Authors:  B Wängberg; H Ahlman; U Tylén; O Nilsson; S Hermodsson; K Hellstrand
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

8.  Immune responses following stereotactic body radiotherapy for stage I primary lung cancer.

Authors:  Yoshiyasu Maehata; Hiroshi Onishi; Kengo Kuriyama; Shinichi Aoki; Masayuki Araya; Ryo Saito; Licht Tominaga; Mitsuhiko Oguri; Tsutomu Araki
Journal:  Biomed Res Int       Date:  2013-11-10       Impact factor: 3.411

Review 9.  Attacking Postoperative Metastases using Perioperative Oncolytic Viruses and Viral Vaccines.

Authors:  Lee-Hwa Tai; Rebecca Auer
Journal:  Front Oncol       Date:  2014-08-12       Impact factor: 6.244

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.